Le Lézard
Classified in: Health
Subjects: AWD, MAT

Renowned Beverly Hills Oculoplastic Surgeon Dr. Kami Parsa Named a 2023 Top Patient Rated Doctor by Find Local Doctors


This prestigious award recognizes Dr. Kami Parsa's exceptional skills and commitment to providing patients with the highest quality care.

BEVERLY HILLS, Calif., July 7, 2023 /PRNewswire-PRWeb/ -- Dr. Kami Parsa, a highly-credentialed oculoplastic and reconstructive surgeon in Beverly Hills, has recently been recognized as a Top Patient Rated Doctor by Find Local Doctors. His patient-centered approach and expert knowledge in oculoplastic procedures have fostered a large volume of outstanding reviews from his patients across multiple online sources. Such superior ratings have led Find Local Doctors, a credible online directory of medical providers, to honor Dr. Kami Parsa with this award. Dr. Parsa is a skilled oculoplastic surgeon who is highly sought-after for his specialization in reconstructive, revisional and cosmetic surgery of the eyes and surrounding tissue. He is known for excellence in cosmetic eyelid surgery, upper eyelid lifts, and minimally-invasive surgical techniques. As a double-board-certified ophthalmologist and oculofacial plastic surgeon, Dr. Parsa is renowned for his artistic approach and meticulous attention to detail.

Over the course of his career, Dr. Kami Parsa has performed thousands of procedures to help patients achieve a refreshed and rejuvenated appearance. He is known across the country for his expertise and has earned numerous awards as a leading Beverly Hills oculoplastic surgeon, appearing on multiple media outlets, such as The Doctors, Botched, The New York Times and the Miami Herald. While Dr. Parsa holds elite qualifications and experience in his field, he passionately pursues new innovative techniques to produce beautiful results with minimal downtime for his patients. Offering cosmetic procedures such as blepharoplasty (eyelid lift) and eyebrow lifts, Dr. Parsa also performs a full menu of complex reconstructive surgeries for the eyes, including those involving ectropion repair, orbital decompression and Bell's Palsy. In addition, at his Beverly Hills practice patients can take advantage of non-surgical treatments in facial rejuvenation using fillers, lasers, micro needling and more.

"My goal has always been to provide compassionate care and achieve natural results for my patients, offering the latest treatments available," says Dr. Kami Parsa.

More about Dr. Kami Parsa:

Kami Parsa M.D. is a native of California. He attended UCLA and graduated with honors from the University of Southern California School of Medicine. Dr. Parsa completed a residency in ophthalmology at USC's prestigious Doheny Eye Institute. He then finished a two-year sub-specialty fellowship in Oculoplastic & Reconstructive Surgery at the University of Miami's Bascom Palmer Eye Institute. Dr. Parsa participates in several humanitarian efforts and is a member of the American Academy of Ophthalmology and fellowship trained by the American Society of Ophthalmic Plastic & Reconstructive Surgeons. He is also a clinical professor at USC's Department of Ophthalmology and Department of Plastic Surgery and has published extensively in leading medical journals and textbooks. Dr. Parsa frequently lectures at major meetings and conferences around the world. For more information about the cosmetic and reconstructive services offered by Dr. Kami Parsa, please call his clinic located at 465 N Roxbury Dr. Suite 1011 in Beverly Hills, CA, at (310) 777-8880 or visit his website at http://www.oculoplastic.info.

Media Contact

Dr. Kami Parsa, Parsa MD Inc, (310) 777-8880, Kamiparsa@gmail.com

 

SOURCE Parsa MD Inc


These press releases may also interest you

at 10:45
eBlu Solutions, a leading provider of innovative technology solutions for the specialty healthcare industry, is pleased to announce the addition of Doug Lawrence to the Executive Leadership team in the role of Chief Revenue Officer. "We're not just...

at 09:18
NUVISTA Mental Health proudly announces its participation as a Gold Sponsor for the 2024 Ontario First...

at 09:05
Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced the presentation of positive clinical data from CARDINAL?HF,...

at 06:05
Dr. Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and Research Centre (KFSH&RC) joined the Gulf Creatives Conference (GCC) at Harvard 2024. The event, GCC at Harvard, is organized by The Diwan, an organization run by graduate students at...

at 06:00
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use across a range of infectious disease, oncology,...

at 03:14
Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention on Wednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in...



News published on and distributed by: